首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   26684篇
  免费   977篇
  国内免费   1695篇
系统科学   703篇
丛书文集   878篇
教育与普及   143篇
理论与方法论   33篇
现状及发展   659篇
研究方法   1篇
综合类   26930篇
自然研究   9篇
  2024年   59篇
  2023年   129篇
  2022年   307篇
  2021年   329篇
  2020年   333篇
  2019年   307篇
  2018年   302篇
  2017年   431篇
  2016年   493篇
  2015年   670篇
  2014年   1130篇
  2013年   891篇
  2012年   1473篇
  2011年   1680篇
  2010年   1455篇
  2009年   1811篇
  2008年   1676篇
  2007年   2112篇
  2006年   1903篇
  2005年   1664篇
  2004年   1416篇
  2003年   1284篇
  2002年   1075篇
  2001年   913篇
  2000年   858篇
  1999年   831篇
  1998年   501篇
  1997年   533篇
  1996年   447篇
  1995年   384篇
  1994年   330篇
  1993年   321篇
  1992年   298篇
  1991年   256篇
  1990年   212篇
  1989年   187篇
  1988年   147篇
  1987年   88篇
  1986年   58篇
  1985年   44篇
  1984年   11篇
  1981年   2篇
  1980年   1篇
  1955年   4篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
基于异烟肼分子结构中的酰肼基具有较强的还原性,可将Fe~(3+)还原为Fe~(2+),选择水合红菲绕啉二磺酸钠作为Fe~(2+)的显色剂,建立了可见分光光度法测定异烟肼的新方法.在最佳实验条件下,异烟肼的浓度在0.04~3.2μg·mL-1范围内符合比尔定律,表观摩尔吸光系数ε=1.14×104 L·mol~(-1)·cm~(-1),检测限为0.033μg·mL~(-1).方法可用于异烟肼片剂和尿样中异烟肼含量的测定.  相似文献   
2.
目的:探讨乙酰胆碱对人胃粘膜上皮细胞和胃腺癌细胞内Ca2 、Mg2 浓度的影响。方法:利用大型生化分析仪,检测了乙酰胆碱作用后培养的人胃粘膜上皮细胞和胃腺癌细胞内Ca2 、Mg2 的浓度。结果:与正常胃粘膜上皮细胞比较,胃腺癌细胞内Ca2 、Mg2 浓度偏低(P>0 01)。在乙酰胆碱作用下,胃粘膜上皮细胞内Ca2 浓度升高(P<0 01),Mg2 浓度降低(P<0 01);胃腺癌细胞仅有Ca2 浓度升高(P<0 05),Mg2 浓度无变化。阿托品能阻断乙酰胆碱的作用(P<0 05)。结论:乙酰胆碱对胃粘膜上皮细胞和胃腺癌细胞的作用是通过毒蕈碱受体实现的。  相似文献   
3.
在探索综合性大学中教师教育的培养模式研究过程中,根据教师教育双专业的特性,实施了综合性大学师范本科教育3+1课程方案和培养模式的研究与实践.并以化学教师教育培养为例对3+1模式的作了具体说明.  相似文献   
4.
关于图的第二特征标R2(G)   总被引:10,自引:2,他引:8  
对任意图G,h(G,x)表示图G的伴随多项式,R2(G)表示图G的第二特征标,本文刻画了R2(G)=-2,-1,0,1,2的全部连通图。  相似文献   
5.
电气自动化成套装置种类繁多,并广泛应用于电力系统.结合现场实际商业运行期所积累的经验,并根据市场预测以及目前工控机发展动态,提出了采用APCI5000工业控制计算机实现电气自动化成套装置设计的最佳方案.  相似文献   
6.
研究了诺氟沙星—铽(Tb^3 )络合物与核酸(DNA)的相互作用,据此建立了核酸的测定方法,讨论了诺氟沙星—铽与DNA分子之间的结合方式。  相似文献   
7.
庄子认为“无”是“道”之本源,“虚”是“道”之禀性,“无”与“虚”蕴藏着勃勃生机。芒德勃罗发现了空集的价值,揭示了自然界虚实相间的生长状态。庄子和芒德勃罗都“以无观有”,认为“无”是“有”潜藏的存在,“无”和“空”是生成万物的根源,在“空隙中生长”是宇宙的常态。芒德勃罗的空集是一种形而下的研究,其指向是现实存在物的实体和空隙合一,是对象性的整体观。庄子之“无”所看重的是人内心世界的空灵,是主客心物合一的非对象性的整体现。  相似文献   
8.
It has been proposed that activation of Toll-like receptors (TLRs) plays crucial roles in the polarization of adaptive immune responses. A synthetic Toll-like receptor 2 (TLR2) ligand, Pam3CSK4, has been reported to modulate the balance of Th1/Th2 responses. We evaluated the modulation effect of Pam3CSK4 on allergic immune response in a mouse rhinitis model sensitized to house dust mite allergen (HDM). Mice were sensitized and challenged with Dermatophagoidesfarinae allergen (Der f), and then the allergic mice were treated by Pam3CSK4. Nasal allergic symptoms and eosinophils were scored. Der f-specific cytokine responses were examined in the splenocytes and bronchoalveolar lavage fluid (BALF). Serum level of total IgE was also detected. After establishing a mouse allergic rhinitis model with HDM, we have showed that Pam3CSK4 treatment not only ameliorated the nasal allergic symptoms remarkably but also decreased the eosinophils and total inflammation cells in BALF significantly. Analysis of cytokine profile found that IFN-7 released from either BALF or stimulated splenocytes increased markedly in Pam3CSK4-treated mice, while IL-13 decreased significantly. Moreover, serum level of total IgE was significantly lower in Pam3CSK4-treated mice than in the untreated. Thus, in an allergic rhinitis mouse model developed with HDM, Pam3CSK4 was shown to exhibit an antiallergic effect, indicating its potential application in allergic diseases.  相似文献   
9.
10.
The purposes of this research were to study the stable expression of exogenous gene encoding therapeutic protein in attenuated Salmonella typhimurium, observe the metabolism of oral gene vaccine carried by attenuated Salmonella typhimurium in BALB/c mouse, and investigate the feasibility of prevention and treatment of tumors by the recombinant bacteria. Recombinant plasmid pcDNA3.1 VEGFR2(n1-7) was transformed into competent attenuated Salmonella typhimurium SL3261 to develop oral DNA vaccine SL3261-pcDNA3.1 VEGFR2(n1-7). To observe whether the exogenous gene can be expressed in the recombinant bacteria, PCR was performed to amplify the CMV promoter of the eukaryotic expression vector as the proof of stable expression of exogenous protein; transmission elec- tron microscopy (TEM) was applied to observe the morphology of the recombinant bacteria to confirm that the exogenous gene has no impact on the growth of the bacteria, and then BALB/c mice were immunized with the gene vaccine. After inoculation of the gene vaccine, the recombinant bacteria SL3261 could be detected in the tissues such as small intestine, colon, liver and spleen. And then, mice in each group were challenged with tumor cells. The results of animal experiment showed that tumor growth of the mice in experimental group was inhibited and survival time of immunized mice was prolonged compared with control groups. A higher lymphocyte infiltration in tumors from animals treated with DNA vaccine was observed. Immunohistochemical analysis of tumor samples revealed an en- hanced accumulation of CD8 cytotoxic T lymphocytes, as well as an increase in CD4 cells in the tumors of animals treated with the oral gene vaccine compared to tumors from control group mice. Ultrastructure of the tumor tissue showed that tumor cells in the samples of the immunized mice were well-differentiated. Our research confirmed that the exogenous gene can be stably expressed in the attenuated Salmonella typhimurium and has no impact on the growth of the recombinant bacteria; the exogenous gene can de delivered to the host by attenuated Salmonella typhimurium to produce anti-tumor effect with no obvious cytotoxity to the host. In this study, it is established that attenuated Salmonella typhimurium could be used as a vector for oral gene vaccine, and our study provided a theoretical basis for the body distribution and the metabolism of the recombinant bacteria. This strategy may provide a simple, safe and effective way for the prevention and treatment of tumors.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号